103 related articles for article (PubMed ID: 21612935)
1. Selective bone targeting 5-fluorouracil prodrugs: synthesis and preliminary biological evaluation.
Ouyang L; He D; Zhang J; He G; Jiang B; Wang Q; Chen Z; Pan J; Li Y; Guo L
Bioorg Med Chem; 2011 Jun; 19(12):3750-6. PubMed ID: 21612935
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary evaluation in vitro of novel naproxen-dendritic peptide conjugates.
Ouyang L; Zhang J; Pan J; Yan L; Guo L
Drug Deliv; 2009 Aug; 16(6):348-56. PubMed ID: 19606949
[TBL] [Abstract][Full Text] [Related]
3. Dual-targeting delivery system for bone cancer: synthesis and preliminary biological evaluation.
Jiang B; Cao J; Zhao J; He D; Pan J; Li Y; Guo L
Drug Deliv; 2012; 19(7):317-26. PubMed ID: 22985302
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of new liver targeting 5-fluorouracil-cholic acid conjugates.
Qian S; Wu JB; Wu XC; Li J; Wu Y
Arch Pharm (Weinheim); 2009 Sep; 342(9):513-20. PubMed ID: 19598290
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of conjugates of 5-Fluorouracil and emodin.
Zhao LM; Zhang LM; Liu JJ; Wan LJ; Chen YQ; Zhang SQ; Yan ZW; Jiang JH
Eur J Med Chem; 2012 Jan; 47(1):255-60. PubMed ID: 22093761
[TBL] [Abstract][Full Text] [Related]
6. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
Singh P; Gupta U; Asthana A; Jain NK
Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
[TBL] [Abstract][Full Text] [Related]
7. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
8. Novel thermosensitive 5-fluorouracil-cyclotriphosphazene conjugates: synthesis, thermosensitivity, degradability, and in vitro antitumor activity.
Cho YW; Lee JR; Song SC
Bioconjug Chem; 2005; 16(6):1529-35. PubMed ID: 16287251
[TBL] [Abstract][Full Text] [Related]
9. Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis.
Houghton TJ; Tanaka KS; Kang T; Dietrich E; Lafontaine Y; Delorme D; Ferreira SS; Viens F; Arhin FF; Sarmiento I; Lehoux D; Fadhil I; Laquerre K; Liu J; Ostiguy V; Poirier H; Moeck G; Parr TR; Far AR
J Med Chem; 2008 Nov; 51(21):6955-69. PubMed ID: 18834106
[TBL] [Abstract][Full Text] [Related]
10. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
Jin Y; Yang F; Du L
Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
[TBL] [Abstract][Full Text] [Related]
11. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
[TBL] [Abstract][Full Text] [Related]
12. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery.
Shen Y; Jin E; Zhang B; Murphy CJ; Sui M; Zhao J; Wang J; Tang J; Fan M; Van Kirk E; Murdoch WJ
J Am Chem Soc; 2010 Mar; 132(12):4259-65. PubMed ID: 20218672
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel conjugates of podophyllotoxin and 5-FU as antineoplastic agents.
Chen SW; Xiang R; Liu J; Tian X
Bioorg Med Chem; 2009 Apr; 17(8):3111-7. PubMed ID: 19324555
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs.
Daumar P; Decombat C; Chezal JM; Debiton E; Madesclaire M; Coudert P; Galmier MJ
Eur J Med Chem; 2011 Jul; 46(7):2867-79. PubMed ID: 21530016
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
Sun W; Zhang N; Li A; Zou W; Xu W
Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
[TBL] [Abstract][Full Text] [Related]
16. Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell.
Calderón M; Welker P; Licha K; Fichtner I; Graeser R; Haag R; Kratz F
J Control Release; 2011 May; 151(3):295-301. PubMed ID: 21256902
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
18. Improving anticancer activity and selectivity of camptothecin through conjugation with releasable substance P.
Zhang W; Song J; Mu L; Zhang B; Liu L; Xing Y; Wang K; Li Z; Wang R
Bioorg Med Chem Lett; 2011 Mar; 21(5):1452-5. PubMed ID: 21282053
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
20. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
